DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability.

Liu, Yaping; Wu, Qiong; Sun, Tiantian; Huang, Junxing; Han, Gaohua; Han, Hexu

Liu, Yaping; Wu, Qiong; Sun, Tiantian; Huang, Junxing; Han, Gaohua; Han, Hexu.

Afiliación

Liu Y; Department of Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Wu Q; Department of Geriatrics, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Sun T; Medical Department, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Huang J; Department of Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Han G; Department of Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Han H; Department of Gastroenterology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.

Front Oncol ; 12: 1032579, 2022.

Article en En | MEDLINE | ID: mdl-36276075

Palabras clave

DNAAF5; HCC; PFKL protein; glycolysis; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google